US health agency to wind down mRNA vaccine development
The unit, Biomedical Advanced Research and Development Authority, helps companies develop medical supplies to address public health threats, and had also provided billions of dollars for development of COVID-19 vaccines during the pandemic.
HHS said the wind down includes cancellation of a contract awarded to Moderna (MRNA.O), opens new tab for the late-stage development of its bird flu vaccine for humans and the right to purchase the shots, a move first reported in May.
The U.S. health agency said it is also rejecting or canceling multiple pre-award solicitations, including proposals from Pfizer (PFE.N), opens new tab, Sanofi Pasteur (SASY.PA), opens new tab, CSL Seqirus (CSL.AX), opens new tab, Gritstone and others.
In total, this affects 22 projects worth nearly $500 million, the agency said.
HHS said the decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
2 hours ago
- The Guardian
Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration (FDA) a little more than a week after he left the agency. 'At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters. Prasad left the agency on 30 July after just a few months as director of the center. Endpoints News, which covers the biotech industry, first reported the return of Prasad. Prasad, an oncologist who was a fierce critic of US Covid-19 vaccine and mask mandates, was named the center's director by the FDA's commissioner, Marty Makary, in May. Criticism of Prasad's tenure intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy (DMD) from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced DMD. After a third death in a separate experimental gene therapy from the company, the FDA asked Sarepta on 18 July to stop all shipments of the approved DMD therapy, saying it had safety concerns. The FDA changed course on Sarepta on 28 July and said shipments to the main group of patients for the drug could restart. Laura Loomer, a far-right influencer and conspiracy theorist with outsized sway over Donald Trump, had called Prasad a 'progressive leftist saboteur' who was undermining the agency's work. Two days before Prasad stepped down last month, Loomer had released misleadingly edited audio to suggest that that Prasad had admitted sticking pins in a Trump voodoo doll, when the full audio made it clear that he was talking about the kind of thing an imagined liberal Trump-hater would do. Loomer reacted to the news of Prasad's return on Saturday by renewing her attacks on him in a social media post in which she promised to produce 'exposes of officials within HHS and FDA' in the weeks ahead. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!' she wrote. Prasad was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of Health. The FDA and other health agencies have seen multiple shake-ups in recent months under the leadership of health secretary Robert F Kennedy Jr.
The Guardian
4 hours ago
- The Guardian
Vinay Prasad returns to FDA days after leaving under pressure from Laura Loomer
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the US Food and Drug Administration (FDA) a little more than a week after he left the agency. 'At the FDA's request, Dr Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,' Department Health and Human Services spokesperson Andrew Nixon said in a statement to Reuters. Prasad left the agency on 30 July after just a few months as director of the center. Stat News first reported the return of Prasad. Prasad, an oncologist who was a fierce critic of US Covid-19 vaccine and mask mandates, was named the center's director by the FDA's commissioner, Marty Makary, in May. Criticism of Prasad's tenure intensified around the agency's handling of a gene therapy for Duchenne muscular dystrophy (DMD) from Sarepta Therapeutics. The FDA-approved therapy played a role in the death of two teens who had advanced DMD. After a third death in a separate experimental gene therapy from the company, the FDA asked Sarepta on 18 July to stop all shipments of the approved DMD therapy, saying it had safety concerns. The FDA changed course on Sarepta on 28 July and said shipments to the main group of patients for the drug could restart. Laura Loomer, a far-right influencer and conspiracy theorist with outsized sway over Donald Trump, had called Prasad a 'progressive leftist saboteur' who was undermining the agency's work. Two days before Prasad stepped down last month, Loomer had released misleadingly edited audio to suggest that that Prasad had admitted sticking pins in a Trump voodoo doll, when the full audio made it clear that he was talking about the kind of thing an imagined liberal Trump-hater would do. Loomer reacted to the news of Prasad's return on Saturday by renewing her attacks on him in a social media post in which she promised to produce 'exposes of officials within HHS and FDA' in the weeks ahead. 'There are several Senate Confirmation hearings coming up and I have multiple oppo books ready for distribution!' she wrote. Prasad was a physician who joined the agency from the University of California, San Francisco. He has had stints at the National Cancer Institute and the National Institutes of Health. The FDA and other health agencies have seen multiple shake-ups in recent months under the leadership of health secretary Robert F Kennedy Jr.
The Sun
4 hours ago
- The Sun
I thought pregnancy would leave me glowing but I ended up unrecognisable – my face left me in tears
A WOMAN has revealed the dramatic change she underwent during pregnancy, with her face looking completely unrecognisable. Farah Faizal (@ayyitslala) thought she was going to look glowing during her pregnancy, but ended up crying over her changing appearance. 2 2 In a viral video, that has racked up 116 million views, Farah shared some snaps of herself before she was pregnant. The brunette beauty looks stunning, with clear skin and gorgeous features. However, she then shared a number of clips of how she looked during her pregnancy, and she is completely unrecognisable. Her nose had almost tripled in size, and her face was extremely red and swollen. "Survived nine months of chaos, cried over my face more than I'd like to admit, and now I'm officially someone's mum", she said. "Healing in progress…" Sharing a snap of herself one month after giving birth, Farah's skin looks a lot less red and swollen, and her nose is beginning to shrink in size. She revealed that she went to the doctor about her condition and has been healing herself with creams and laser treatment. Thankfully, Farah revealed that her husband was extremely supportive during her pregnancy, and helped her through every "breakdown". "He constantly reminded me that I was beautiful strong and loved", she said. I thought I was glowing in my pregnancy until my NOSE popped at week 25 - people say it looks like I've used a filter More than 40% of women experience acne during pregnancy, which is caused by hormonal changes. Many women also experience their noses growing in size. "Although 'pregnancy nose' is not a medical term, many women's noses do appear to be bigger toward the end of pregnancy, and they may also experience more frequent nasal drainage than prior to pregnancy," says Jessica Madden, M.D., IBCLC, a board-certified neonatologist, pediatrician, lactation consultant, and the medical director of Aeroflow Breastpumps. How to reduce pregnancy nose Face yoga instructor Angela Rosoff has revealed her free techinque to reduce the size of your nose during pregnancy. She starts with cleansing her face before applying a "light facial oil or serum." Next, she gets into position by pressing her index fingers on either side of her nose. "Start the compression," she said. "Place your fingers at the base of your nose, near the nostrils. "Compress and release. Gently press the sides of your nose together and hold for two to three seconds, then release." She then repeats the process 10 to 15 times, finishing off by massaging around the nose in soft, circular motions.
